The Atlantic, Aug. 31, 2020
With more than more than 100 COVID-19 vaccines, therapies, and drugs in development, there is a national shortage of monkey’s typically used for biomedical research. But UTMB’s Vineet Menachery tells The Atlantic that hamsters may actually be a better test subject. This news also reported in DNYUZ and MSN.com